MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹10,655 Cr | ₹9,187 Cr | ₹7,745 Cr | ₹6,848 Cr | ₹5,791 Cr |
What is the latest Total Expenditure of MANKIND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹10,655 Cr |
| Mar2025 | ₹9,187 Cr |
| Mar2024 | ₹7,745 Cr |
| Mar2023 | ₹6,848 Cr |
| Mar2022 | ₹5,791 Cr |
How is Total Expenditure of MANKIND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹10,655 Cr | 15.98 | |
| Mar2025 | ₹9,187 Cr | 18.61 | |
| Mar2024 | ₹7,745 Cr | 13.11 | |
| Mar2023 | ₹6,848 Cr | 18.24 | |
| Mar2022 | ₹5,791 Cr | - | |
Compare Total Expenditure of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹106,428.0 Cr | 2.9% | 3.5% | -0.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 2.9% |
3.5% |
-0.3% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses